Immunocore Holdings Plc (IMCR)
30.98
-1.14
(-3.55%)
USD |
NASDAQ |
Oct 23, 16:00
31.07
+0.09
(+0.29%)
After-Hours: 20:00
Immunocore Holdings EPS Diluted (Quarterly) : -0.0159 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0159 |
| March 31, 2026 | 0.2446 |
| December 31, 2025 | -0.5948 |
| September 30, 2025 | -0.0035 |
| June 30, 2025 | -0.2073 |
| March 31, 2025 | 0.0971 |
| December 31, 2024 | -0.4706 |
| September 30, 2024 | 0.1671 |
| June 30, 2024 | -0.2325 |
| March 31, 2024 | -0.4896 |
| December 31, 2023 | -0.4018 |
| September 30, 2023 | 0.0445 |
| Date | Value |
|---|---|
| June 30, 2023 | -0.3507 |
| March 31, 2023 | -0.4073 |
| December 31, 2022 | -0.6147 |
| September 30, 2022 | 0.1423 |
| June 30, 2022 | -0.1756 |
| March 31, 2022 | -0.4962 |
| December 31, 2021 | -1.226 |
| September 30, 2021 | -0.9507 |
| June 30, 2021 | -1.049 |
| March 31, 2021 | -1.048 |
| December 31, 2020 | -0.7844 |
| December 31, 2019 | -0.7898 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.0866 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.007 |
| Mereo BioPharma Group Plc | -0.0437 |
| Compass Pathways Plc | -1.883 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.8095M |
| Revenue (Quarterly) | 116.14M |
| Total Expenses (Quarterly) | 116.95M |
| Enterprise Value | 1.150B |
| Gross Profit Margin (Quarterly) | 98.18% |
| Profit Margin (Quarterly) | -0.70% |
| Earnings Yield | -1.19% |
| Normalized Earnings Yield | -1.827 |